Mohammad Saleem

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi Lupeol triterpene, a novel diet-based microtubule targeting agent: disrupts survivin/cFLIP activation in prostate cancer cells
    Mohammad Saleem
    School of Medicine and Public Health, University of Wisconsin, 1300 University Avenue, MSC 4385, Madison, WI 53719, USA
    Biochem Biophys Res Commun 388:576-82. 2009
  2. ncbi Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene
    Mohammad Saleem
    School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI 53719, USA
    Cancer Lett 285:109-15. 2009
  3. ncbi Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator
    Bilal Bin Hafeez
    Department of Dermatology, University of Wisconsin, 1300 University Avenue, Medical Science Center, B 25, Madison, WI 53706, USA
    Clin Cancer Res 15:452-9. 2009
  4. ncbi Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, 1300 University Avenue, MSC 25B, Madison, WI 53706, USA
    Carcinogenesis 30:808-17. 2009
  5. ncbi Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, Madison, Wisconsin 53706, USA
    Clin Cancer Res 14:2119-27. 2008
  6. ncbi A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling
    Bilal Bin Hafeez
    Department of Dermatology, University of Wisconsin, Madison, Wisconsin 53706, USA
    Cancer Res 68:8564-72. 2008
  7. ncbi Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB
    Imtiyaz Murtaza
    Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA
    Int J Cancer 125:2465-73. 2009
  8. ncbi Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo
    Vaqar Mustafa Adhami
    Department of Dermatology, University of Wisconsin Madison, Madison, Wisconsin 53706, USA
    Clin Cancer Res 13:1611-9. 2007
  9. ncbi Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate
    Naghma Khan
    Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
    Cancer Res 66:2500-5. 2006
  10. ncbi Tea beverage in chemoprevention and chemotherapy of prostate cancer
    Imtiaz A Siddiqui
    Department of Dermatology, University of Wisconsin, Medical Sciences Center, Room B 25 1300 University Avenue, Madison, Wisconsin 53706, USA
    Acta Pharmacol Sin 28:1392-408. 2007

Collaborators

Detail Information

Publications20

  1. ncbi Lupeol triterpene, a novel diet-based microtubule targeting agent: disrupts survivin/cFLIP activation in prostate cancer cells
    Mohammad Saleem
    School of Medicine and Public Health, University of Wisconsin, 1300 University Avenue, MSC 4385, Madison, WI 53719, USA
    Biochem Biophys Res Commun 388:576-82. 2009
    ..We suggest that Lupeol alone or as an adjuvant to other microtubule agents could be developed as a potential agent for the treatment of human CaP...
  2. ncbi Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene
    Mohammad Saleem
    School of Medicine and Public Health, University of Wisconsin Madison, Madison, WI 53719, USA
    Cancer Lett 285:109-15. 2009
    ..This mini review provides detailed account of preclinical studies conducted to determine the utility of Lupeol as a therapeutic and chemopreventive agent for the treatment of inflammation and cancer...
  3. ncbi Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator
    Bilal Bin Hafeez
    Department of Dermatology, University of Wisconsin, 1300 University Avenue, Medical Science Center, B 25, Madison, WI 53706, USA
    Clin Cancer Res 15:452-9. 2009
    ..Because Notch1 was found to be overexpressed in prostate cancer (PCa) cells and human PCa tissue, we therefore tested our hypothesis that overexpression of Notch1 in PCa promotes tumor invasion...
  4. ncbi Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, 1300 University Avenue, MSC 25B, Madison, WI 53706, USA
    Carcinogenesis 30:808-17. 2009
    ..We suggest that Lupeol could be developed as an agent for chemoprevention as well as chemotherapy of human CaP...
  5. ncbi Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, Madison, Wisconsin 53706, USA
    Clin Cancer Res 14:2119-27. 2008
    ..In this study, the effect of lupeol, a diet-based triterpene, was determined on the growth and tumorigenicity of human melanoma cells in vitro and in vivo...
  6. ncbi A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling
    Bilal Bin Hafeez
    Department of Dermatology, University of Wisconsin, Madison, Wisconsin 53706, USA
    Cancer Res 68:8564-72. 2008
    ..Analysis of tumors from delphinidin-treated mice showed significant decrease in the expression of NF-kappaB/p65, Bcl2, Ki67, and PCNA. Taken together, our data suggest that delphinidin could be developed as an agent against human PCa...
  7. ncbi Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB
    Imtiyaz Murtaza
    Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA
    Int J Cancer 125:2465-73. 2009
    ..These data provide evidence that fisetin could provide a biological rationale for treatment of pancreatic cancer or as an adjuvant with conventional therapeutic regimens...
  8. ncbi Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo
    Vaqar Mustafa Adhami
    Department of Dermatology, University of Wisconsin Madison, Madison, Wisconsin 53706, USA
    Clin Cancer Res 13:1611-9. 2007
    ....
  9. ncbi Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate
    Naghma Khan
    Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
    Cancer Res 66:2500-5. 2006
    ..This review discusses the modulations of important signaling events by EGCG and their implications in cancer management...
  10. ncbi Tea beverage in chemoprevention and chemotherapy of prostate cancer
    Imtiaz A Siddiqui
    Department of Dermatology, University of Wisconsin, Medical Sciences Center, Room B 25 1300 University Avenue, Madison, Wisconsin 53706, USA
    Acta Pharmacol Sin 28:1392-408. 2007
    ..In this review we address the issue of possible use of tea, especially green tea, for the prevention as well as treatment of PCa...
  11. ncbi Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells
    Imtiyaz Murtaza
    Department of Dermatology, University of Wisconsin Madison, Madison, Wisconsin 53706, USA
    Cancer Res 69:1156-65. 2009
    ..We suggest that lupeol, alone or as an adjuvant to current therapies, could be useful for the management of human PaC...
  12. ncbi Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention
    Jeremy J Johnson
    Division of Pharmacy Practice, University of Wisconsin School of Pharmacy, 1031 Rennebohm Hall, Madison, WI 53705, USA
    Cancer Prev Res (Phila) 3:1112-23. 2010
    ..We suggest that carnosol may be developed or chemically modified through more rigorous structure-activity relationship studies for a new class of investigational agents-a dual AR/ER modulator...
  13. ncbi S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA
    Proc Natl Acad Sci U S A 103:14825-30. 2006
    ..We suggest that S100A4 could be used as a biomarker for CaP progression and a novel therapeutic or chemopreventive target for human CaP treatment...
  14. ncbi Specific targeting of Wnt/?-catenin signaling in human melanoma cells by a dietary triterpene lupeol
    Rohinton S Tarapore
    Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, WI 53706, USA
    Carcinogenesis 31:1844-53. 2010
    ..We suggest that lupeol alone or as an adjuvant to current therapies could be developed as an agent for the management of human melanomas harboring constitutive Wnt/?-catenin signaling...
  15. ncbi A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, Madison, Wisconsin 53706, USA
    Cancer Res 65:11203-13. 2005
    ..Because early clinical prostate cancer growth is an androgen-dependent response, the results of the present study suggest that Lupeol may have a potential to be an effective agent against prostate cancer...
  16. ncbi A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1
    Mohammad Saleem
    Department of Dermatology, Laboratory of Medicine, University of Wisconsin, 1300 University Avenue, Medical Sciences Center, B 25, Madison, Wisconsin 53706, USA
    Cancer Epidemiol Biomarkers Prev 15:217-27. 2006
    ..Here, we establish the clinical significance of matriptase and its inhibitor, hepatocyte growth factor activator inhibitor-1 (HAI-1), during the progression of human prostate cancer (CaP)...
  17. ncbi Beneficial effects of tea and its polyphenols against prostate cancer
    Imtiaz A Siddiqui
    Department of Dermatology, University of Wisconsin, Medical Sciences Center, Madison, WI 53706, USA
    Mol Nutr Food Res 50:130-43. 2006
    ..In this review we attempt to summarize the experimental as well as the epidemiological basis for the possible role of tea and its polyphenols for chemoprevention and chemotherapy of CaP...
  18. ncbi Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA
    Carcinogenesis 26:1956-64. 2005
    ..Lupeol could be a potential agent against pancreatic cancer, however, further in-depth in vivo studies are warranted...
  19. ncbi Tea beverage in chemoprevention of prostate cancer: a mini-review
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, 1300 Medical Science Center, Madison, WI 53706, USA
    Nutr Cancer 47:13-23. 2003
    ..This article attempts to address the issue of the possible use of tea, especially green tea, for the chemoprevention of prostate cancer...
  20. ncbi Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice
    Mohammad Saleem
    Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA
    Oncogene 23:5203-14. 2004
    ..We suggest that Lupeol is an attractive antitumor-promoting agent that must be evaluated in tumor models other than skin carcinogenesis...

Research Grants2

  1. Lupeol, A Novel Fuit and Vegetable Based Triterpene for Prostate Cancer
    MOHAMMAD BHAT; Fiscal Year: 2007
    ..We believe that this application will be extremely valuable in providing a novel fruit and vegetable based agent for chemoprevention and possibly for treating prostate cancer ..